Skip to main content
Erschienen in: Annals of Surgical Oncology 1/2022

Open Access 12.08.2021 | Endocrine Tumors

Thyroglobulin Measurement Through Fine-Needle Aspiration for Optimizing Neck Node Dissection in Papillary Thyroid Cancer

verfasst von: Xi Jia, MD, Yuanbo Wang, MD, Yan Liu, MD, Xiang Wang, MD, Xiaobao Yao, MD, Runyi Tao, BA, Hui Liu, MA, Aimin Yang, MD, PhD, Rui Gao, MD, PhD

Erschienen in: Annals of Surgical Oncology | Ausgabe 1/2022

Abstract

Background

Thyroglobulin measurement in fine-needle aspiration (FNA-Tg) is an additional diagnostic tool of lymph node metastasis (LNM) in papillary thyroid carcinoma (PTC). However, its performance as a preoperative indicator of lateral neck LNM in PTC is unclear. We evaluated the use of FNA cytology and FNA-Tg to detect neck LNM presurgery using a simple methodology, and established a cut-off value for diagnosing LNM in PTC.

Methods

We performed a retrospective cohort study based on hospital records, including 299 FNA-Tg measurements from 228 patients with PTC. The cut-off value for FNA-Tg was obtained through a receiver operating characteristic (ROC) curve analysis. The relationships between various parameters and FNA-Tg were analyzed using Spearman’s correlation.

Results

Of 299 lymph nodes (LNs) from 228 patients following surgery, 151 were malignant and 148 were benign. The median FNA-Tg levels were 414.40 ng/mL and 6.36 ng/mL in the metastatic and benign LNs, respectively. An FNA-Tg cut-off value of 28.3 ng/mL had the best diagnostic performance (93.38% sensitivity, 70.27% specificity, area under the ROC curve [AUC] 0.868) in the whole cohort. The diagnostic value performed better in the lateral neck group (level II–V, n = 163) than in the central neck group (level VI, n = 136); in the lateral neck group, the sensitivity and specificity of the FNA-Tg cut-off (16.8 ng/mL) were 96.25% and 96.36%, respectively.

Conclusions

FNA-Tg is a useful technique for the diagnosis of LNM before surgery, especially in lateral neck dissection.

Clinical trial registration number

ChiCTR1900028547.
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1245/​s10434-021-10549-2.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Thyroid carcinoma is the most common endocrine malignancy. Papillary thyroid carcinoma (PTC), which is frequently associated with cervical lymph node metastasis (LNM), accounts for most thyroid carcinoma cases.1,2 The extent of the initial surgical approach relies on the accurate diagnosis of regional nodal metastases, especially lateral LNM (LLNM).35 Although extensive dissection could achieve a better diagnosis for LLNM, it has a higher potential for nerve injury and hemorrhage. Therefore, lateral compartment dissection is only recommended with fair evidence of LLNM, as per American Thyroid Association (ATA) guidelines.6
Less-invasive approaches, such as ultrasound (US)-guided fine-needle aspiration cytology (FNAC), are therefore commonly used. Unfortunately, false-negative (6–18%) and non-diagnostic (up to 20%) results are common, resulting in high rates of misdiagnosis.710 To improve the diagnostic accuracy of FNAC, thyroglobulin measurement through FNA (FNA-Tg) is frequently practiced in the preoperative diagnosis of LNM in PTC. In most studies, FNA-Tg provides additional diagnostic value for locoregional recurrence post-surgery, although its cut-off values are still controversial.11 To avoid missing metastatic disease in patients who may benefit from lymphadenectomy, a combination of FNAC and FNA-Tg has been applied to accurately differentiate LLNM from benign LNs;7 however, it is unclear whether FNA-Tg measurements could effectively indicate lateral neck LNM in PTC.
In the present study, we aimed to investigate the diagnostic value of FNA-Tg for the detection of LNM from PTC presurgery using a simple methodology, especially the lateral lymph nodes (LNs), and thus guide the necessity of lateral neck dissection.

Materials and Methods

Patients

A total of 593 US-guided FNAs for cervical LNs were performed at The First Affiliated Hospital of Xi’an Jiaotong University in April–December 2019. A consecutive series of 445 patients with single or multiple suspicious cervical LNs underwent US-guided FNA to measure Tg levels (FNA-Tg). When multiple suspicious LNs were presented in one compartment, the representative nodes were selected for FNA. Only patients in whom PTC was confirmed by surgery were included in the study. Finally, a total of 299 LN samples from 228 patients were investigated (Fig. 1).
We categorized dissected LNs as central (level VI) or lateral (level II–V) based on the American Joint Committee on Cancer classification (Eighth Edition). In total, 136 central LNs and 163 lateral LNs were included. The study was approved by the Hospital Ethics Committee of the First Hospital of Xi’an Jiaotong University (XJTU-ZD10) and registered in the Chinese Clinical Trial Register (registration number ChiCTR1900028547).

Ultrasound and Ultrasound-Guided Fine-Needle Aspiration

All 445 patients underwent US using a 10–12 MHz linear transducer prior to surgery, by experienced radiologists. Suspicious US characteristics included hyperechogenicity, cystic changes, calcification, abnormal vascularity, heterogeneous echogenicity, a round shape (longitudinal/transverse diameter ratio < 1.5), and a loss of echogenic hilum. The locations (levels II–VI) of all cervical LNs were recorded based on the guidelines of the American Joint Committee on Cancer classification.7,12 When discordant results existed among different examiners, agreement was reached after a joint review and discussion of the data.
US-guided FNA was simultaneously performed using 22-gauge needles. Every suspicious LN was aspirated twice to guarantee enough samples for analysis. The needle was repeatedly inserted into the LN until sufficient material filled the needle hub. Immediately after the first aspirate was expelled onto glass, 5 µL of the sample was added to 195 µL of Tg-free serum. The clear supernatant after centrifugation was used for subsequent FNA-Tg measurement, and the remainder of the aspirate was smeared for cytological examination (FNAC). After smearing the sample from the second aspiration, the remainder of the material was rinsed in saline for processing as a cell block. All smears were immediately placed in 95% alcohol for Papanicolaou staining. We classified the cytologic specimens into three categories—malignant, benign, and inadequate. If the cytology showed hemosiderin-laden macrophages, the specimen was classified as inadequate.

Thyroglobulin Assessment

Tg was assayed using a monoclonal antibody immunoradiometric assay (IRMA; CIS Bios International, Gif-sur-Yvette, France). The functional sensitivity was 0.9 mg/L, analytical sensitivity was 0.2 ng/mL, and the interassay coefficient of variation (CV) was 6.9%. Values exceeding the maximum Tg were recorded as > 500 ng/mL. Serum Tg autoantibodies were measured using the Siemens IMMULITE 2000 (New York, NY, USA) assay (functional sensitivity, 40 kIU/L; analytical sensitivity, 20 kIU/L; and CV, 9%).

Surgical Protocol and Histopathological Analyses

The extent of surgery was based on the results of FNAC + FNA-Tg. (1) When FNAC revealed malignant cells in the LNs, cervical neck dissection was performed along with total thyroidectomy. Cervical neck dissection involved central with/without unilateral/bilateral lateral compartment (levels II–V) dissection.13,14 (2) When the FNA-Tg levels were higher than 100 ng/mL in cases with negative cytological findings, neck dissection was also suggested in initial surgery.14,15 (3) In patients having LNs with suspicious US features but no definite metastatic cells found in FNAC and a level of FNA-Tg lower than 100 ng/mL, frozen section histologic analysis was only performed in cases required for it.
Final positive diagnoses required histological confirmation of metastatic thyroid carcinoma or clinical evidence of metastasis at follow-up, including an increased LN size observed by sonography and/or persistently increasing serum Tg. The examination was undertaken at least twice yearly. Negative diagnoses were cases free of metastatic disease by the same criteria, based on a negative thyroid-stimulating hormone (TSH)-stimulated Tg measurement or negative follow-up sonography.13

Statistical Analyses

Data following a normal distribution are expressed as mean ± standard deviation (SD), and non-normally distributed data are expressed as median (interquartile range). The Chi-square test was used to compare counting data between groups, and measurement data were evaluated using Student’s t-test or Mann–Whitney U test. A receiver operating characteristic (ROC) curve analysis was used to determine the cut-off value of FNA-Tg for diagnosis of malignant LNs. The area under the ROC curve (AUC) and the confidence interval (CI) were also determined. Spearman’s correlation coefficients were used to estimate relationships between FNA-Tg and other parameters, while binary logistic regression was used to estimate multiple correlations between FNA-Tg results and other parameters. Using the pROC package in R, AUC, sensitivity, specificity, and 95% CIs were calculated under the negative binomial distribution. ROC curves were derived using the ‘pROC’ package in R (version 3.6.1; http://​www.​R-project.​org).16,17 Other statistical analyses were performed in SPSS (version 24.0; IBM Corporation, Armonk, NY, USA). A p-value < 0.05 was considered significant.

Results

Patient Characteristics

The clinicopathologic characteristics of patients are summarized in Table 1. This study included 165 women (72.37%) and 63 men (27.63%), and patient ages ranged from 20 to 81 years (43.80 ± 11.85 years). Aspirated LNs were located at level II (n = 5), level III (n = 48), level IV (n = 101), level V (n = 9), and level VI (n = 136). Of the 228 patients who received thyroidectomy with neck dissection, 160 were given thyroidectomy with central LN dissection (CLND) only, 58 were given unilateral lateral LN dissection (LLND), and 10 were given bilateral LLND. A total of 265 (88.63%) LNs were ipsilateral and 34 (11.37%) were contralateral to the primary tumor. Metastatic LNs with bilateral cancers were considered ipsilateral LNs (27 patients with 36 LNs). Serum TSH and serum Tg levels did not differ between central LNs and lateral LNs (p = 0.237 and p = 0.295, respectively). Serum TgAb was higher in central LNs than in lateral LNs (p = 0.001). It is worth noting that LN sizes in the central neck were significantly smaller than those in the lateral neck (median 6.00 mm vs. 9.00 mm, p = 0.000) (Table 2).
Table 1
Patient characteristics
 
Final outcome
LND outcome
Total patients
Total lymph nodes
228
299
158
205
Age at diagnosis, years
43.80 ± 11.85
0.000a
41.67 ± 11.60
0.018a
Groups, < 55 years/≥ 55 years
185/43
0.010b
136/22
0.229b
Sex
 
0.009b
 
0.000b
Male
63 (27.63%)
 
119 (75.32%)
 
Female
165 (72.37%)
 
39 (24.68%)
 
Primary tumor
    
BRAF
181 (79.39%)
0.372b
122 (77.22%)
0.884b
Multifocality
66 (28.95%)
0.170b
43 (27.22%)
0.027a
Hashimoto
60 (26.32%)
0.092b
56 (35.44%)
0.006b
Lymph node
    
Location 1: Central/Lateral
136/163
0.289b
131/74
0.000b
Location 2: levels 2/3/4/5/6
5/48/101/9/136
0.670c
2/26/41/5/131
0.000c
Location 3: ipsilateral/contralateral
265/34
0.001b
198/7
0.238b
The follow-up results were only included in the final outcome, not in the LND outcome
LND lymph node dissection
aDerived from the two-sample t test
bDerived from the Chi-square test
cDerived from the Fisher’s exact test
Table 2
Clinical parameters comparation
 
Central [n = 136]
Lateral [n = 163]
p-Value
FNA-Tg
156.75 (33.95, 500.00)
15.00 (0.00, 500.00)
0.000
Serum-Tg
9.71 (1.00, 19.25)
11.50 (1.31, 25.35)
0.295
TgAb
80.65 (18.48, 373.72)
38.10 (3.07, 121.90)
0.001
TSH
1.57 (0.98, 2.62)
1.42 (0.75, 2.35)
0.237
LNDmax
6.00 (4.00, 7.00)
9.00 (5.00, 13.00)
0.000
The follow-up results were only included in the final outcome, not in the LND outcome
FNA-Tg fine-needle aspirated thyroglobulin, LNDmax maximum diameter of lymph node, LND lymph node dissection, TSH thyroid-stimulating hormone, Tg thyroglobulin, TgAb thyroglobulin antibody

Final Diagnosis

In the final diagnosis, 151 (50.50%) nodes were positive for metastatic disease and the remaining 148 (49.50%) were negative. The positive nodes were determined by histopathology (n = 130), cytology (n = 13), and follow-up evidence (n = 8). The 148 negative nodes were determined by histological diagnosis (n = 74) and follow-up sonography (n = 74).
FNA-Tg was higher in malignant LNs than in benign LNs in the central group, lateral group, and the total samples. The median FNA-Tg values for the lateral group measured in metastatic and benign LNs were 498.45 ng/mL (130.60, 500 ng/mL) and 0 ng/mL (0, 3.40 ng/mL), respectively. Other serum parameters revealed no significant differences between malignant and benign LNs in the lateral group (Table 3).
Table 3
Comparison of parameters according to the different groups
 
Benign [n = 148]
Malignant [n = 151]
p-Value
FNA-Tg
   
Whole
6.36 (0.00, 47.02)
414.40 (118.20, 500.00)
0.000
Central
49.40 (23.50, 257.40)
322.40 (91.20, 500.00)
0.000
Lateral
0.00 (0.00, 3.40)
498.45 (130.60, 500.00)
0.000
Serum-Tg
   
Whole
8.47 (1.00, 19.90)
11.86 (1.32, 26.00)
0.106
Central
8.39 (1.00, 21.50)
10.05 (1.00, 18.70)
0.557
Lateral
8.47(1.00,19.10)
13.65 (2.51, 35.10)
0.077
Serum-TgAb
   
Whole
69.40 (18.8, 206.60)
36.35 (2.67, 168.25)
0.035
Central
119.30 (27.80, 375.60)
54.40 (5.56, 373.10)
0.192
Lateral
51.45 (8.30, 131.92)
30.90 (1.00, 69.40)
0.061
TPO
   
Whole
1.00 (1.00, 822.00)
1.00 (1.00, 592.00)
0.399
Central
124.40 (1.00, 1355.98)
1.00 (1.00, 543.00)
0.159
Lateral
1.00 (1.00, 374.60)
1.00 (1.00, 688.25)
0.920
TSH
   
Whole
1.60 (0.88, 2.44)
1.37 (0.89, 2.43)
0.723
Central
1.68 (1.12, 2.49)
1.40 (0.89, 2.67)
0.903
Lateral
1.47 (0.75, 2.38)
1.36 (0.64, 2.35)
0.710
LNDmax
   
Whole
7.00 (4.00, 11.00)
6.00 (3.75, 10.25)
0.345
Central
6.00 (4.25, 7.00)
5.00 (1.40, 7.00)
0.120
Lateral
9.00 (4.00, 13.00)
9.00 (6.00, 14.25)
0.629
FNA-Tg fine-needle aspirated thyroglobulin, LNDmax maximum diameter of lymph node, LND lymph node dissection, TSH thyroid-stimulating hormone, Tg thyroglobulin, TgAb thyroglobulin antibody, TPO Thyroid peroxidase

Cut-Off Values for Thyroglobulin Measurement in Fine-Needle Aspiration (FNA-Tg)

In the lateral LNs (n = 163), an FNA-Tg cut-off of 16.80 ng/mL was the best diagnostic value, with 96.25% sensitivity and 96.39% specificity (AUC 0.967) (Fig. 2a). Negative and positive predictive values were 96.39% and 96.25%, respectively. An FNA-Tg cut-off of 119.85 ng/mL had the best diagnostic performance in the central cervical LNs (n = 136), with sensitivity and specificity of 73.24% and 67.69%, respectively (AUC = 0.725) (Fig. 2b). When taken as a whole, 28.3 ng/mL was the best cut-off value, with a sensitivity and specificity of 93.38% and 70.27%, respectively (AUC = 0.868) (Fig. 2c).

Parameters Associated with FNA-Tg

To evaluate the factors associated with FNA-Tg levels in cervical LNs, we examined the correlations between FNA-Tg levels and other clinical parameters. Interestingly, only the serum TgAb levels for central LNs correlated negatively with FNA-Tg levels (Spearman’s correlation coefficient = − 0.232, p = 0.028), although the significant correlation of these two parameters was not observed in the lateral or whole groups. Serum Tg, TSH, or Hashimoto disease were not significantly correlated with FNA-Tg levels in all three groups (Table 4).
Table 4
FNA-Tg correlation with the clinical test results
 
SerumTg
TgAb
TPO
TSH
Hashimoto
Whole group
     
Correlation coefficient
0.079
− 0.086
0.009
− 0.025
− 0.011
p-Value
0.209
0.246
0.917
0.715
0.870
Central group
     
Correlation coefficient
0.109
− 0.232
− 0.088
− 0.081
0.113
p-Value
0.238
0.028
0.492
0.404
0.267
Lateral group
     
Correlation coefficient
0.135
− 0.101
− 0.017
0.036
− 0.056
p-Value
0.121
0.330
0.885
0.706
0.541
FNA-Tg fine-needle aspirated thyroglobulin, TSH thyroid-stimulating hormone, Tg thyroglobulin, TgAb thyroglobulin antibody, TPO Thyroid peroxidase

Extent of Neck Dissection Based on Fine-Needle Aspiration Cytology and FNA-Tg

Further analysis was performed to evaluate whether the FNA-Tg cut-off value for diagnosing LNM could optimize the extent of surgery. The results for total thyroidectomy with LN dissection (LND) are summarized in Table 5. Among 131 central neck LNs, 92 (70.23%) demonstrated negative FNAC before surgery; however, postsurgical histopathological analyses revealed metastatic disease in 29 of these cases (29/92, 31.52%).
Table 5
FNA-Tg diagnosis, cytology and histology with total thyroidectomy with LND are summarized
 
FNAC−
FNAC+
 
Histology+
Histology−
Histology+
Histology−
Central group
    
Tg+
16
21
33
0
Tg−
13
42
6
0
Lateral group
    
Tg+
4
1a
55
0
Tg−
1
11
2
0
FNA-Tg fine-needle aspirated thyroglobulin, Tg thyroglobulin, FNAC fine-needle aspiration cytology, LND lymph node dissection
aThe inadequate cytology whose histology was negative was confirmed metastasis by 131-I imaging
The diagnosis of FNA-Tg performed better in lateral neck LNs than in central neck LNs. In total, 74 LNs with clear results via FNAC were removed during lateral LND (LLND), 17 of which (22.97%) showed FNAC-negative presurgery. In 5 of 17 LNs (29.41%), metastatic disease was detected after LLND. The FNA-Tg estimates for four of five metastatic LNs exceeded the validated cut-off of 16.80 ng/mL for diagnosing metastasis (median 46.30 ng/mL, range 8.50–500.00 ng/mL). It is noteworthy that FNA-Tg measurements for all benign LNs were < 16.80 ng/mL (median 0.00 ng/mL, range 0.00–12.20 ng/mL).

Discussion

Although FNAC is the cornerstone in the diagnosis of cervical LNs, the accuracy highly depends on the experience of the cytopathologist and the adequacy of the aspirates. Clinicians consider FNA-Tg as an important adjunct to FNAC to avoid missing patients with metastatic disease. Our results demonstrated the added value of FNA-Tg for guiding surgical decisions for patients with PTC, especially for determining the need for LLND. In total, 11 of 94 cases (11.83%) were judged as ‘benign’, and 1 of 1 case (100%) judged as ‘inadequate’ by FNAC received LLND based on elevated FNA-Tg in LLN, and, in these cases, metastatic disease was revealed by postsurgical pathology. In most studies, the combination of FNA-Tg and FNAC showed a more optimal diagnostic yield than either FNAC or FNA-Tg alone.7,18,19 In the present study, the AUC of FNAC + FNA-Tg was higher than that of FNA-Tg alone (0.969 vs. 0.967), or that of FNAC alone (0.969 vs. 0.931) in the lateral group, although with no significant differences (p = 0.867 and 0.063, respectively). This suggested that using FNA-Tg alone without FNAC might be a choice in lateral LNs as it can offer comparable results at a much lower cost.7 The excellent negative predictive value could reduce the frequency of recytological examination, and the superior sensitivity could avoid the risk of reoperative complications, the extent of resection, and the cost of reoperation after the initial surgery.
In our study, the diagnostic accuracy of the whole group is consistent with that reported in previous research.2024 Compared with the absolute value, the difference or ratio between FNA-Tg and serum Tg showed no diagnostic advantage (data not shown). However, the sensitivity and specificity values for the central group were much lower than their estimates for the overall group. LNs in the central region are more easily affected by blood contamination by circulating Tg at the time of sampling, or Tg leakage into the LN by lymph vessel draining.7,25,26 In the present study, only serum TgAb levels correlated negatively with FNA-Tg in the central LN group. It is quite possible that underestimation of the FNA-Tg concentration occurs, to some degree, in the presence of circulating TgAb in the central LN region but not in the lateral region.27 Consistent with correlation results, the number of TgAb positive cases with false negative results in the central group was significantly higher than in the lateral group (p = 0.023) [electronic supplementary table]. This might explain why LNs near the thyroid gland (e.g. paratracheal, pretracheal, and prelaryngeal nodes) before thyroidectomy yield inaccurate FNA-Tg values, irrespective of node pathology.2830
FNA-Tg results are informative for LNs when the smallest diameter is < 10 mm. FNA-Tg is particularly recommended in cases involving small, partially cystic LNs, as a significantly increased rate of non-diagnostic cytological results are indicated in these cases.19,31,32 Our study highlighted the efficacy of FNA-Tg for small LNMs in the lateral neck. It is noteworthy that all nine LLNMs, not larger than 5 mm, were successfully identified by FNA-Tg, supporting its routine use in preoperative planning to determine the extent of lateral neck dissection. Further large-scale and high-quality clinical trials are warranted to confirm its effectiveness.
There is wide debate regarding FNA-Tg cut-off values. The high variation among FNA procedures and sample preparation protocols contributes greatly to the different cutoff values used in different studies.3341 It is not surprising that these differences result in substantial variation in the detection of cell density in specimens among studies, which could lead to the observation of a wide range of FNA-Tg levels in PTC LNM.41 In this study, we compensated for this variation in sample dilution by adopting a quantitative analytic method in which a fixed amount of the FNA aspirate (5 µL) was diluted in Tg-free serum. The diagnostic value and best cut-off value were comparable with those reported in previous studies.20,33 Our standardized parameters, including the matrix type and volume of the aspirated sample, offer a potential standard operating procedure for further research, thereby enabling comparisons among studies.
Several limitations of the present study should be considered. First, the number of patients recruited was relatively small, and, additionally, other types of pathology other than PTC were not included in this study. FNA-Tg levels could be undetectable in some types of thyroid cancers, such as poorly differentiated thyroid cancer,42,43 which corresponds to the amount and intensity of Tg expression parallel with differentiation of the tumors. Furthermore, the number of metastatic disease cases, which was confirmed by postoperative histology, was relatively small, therefore future large-scale studies with longer follow-up periods are needed to verify our results. Second, we could not perform a node-by-node analysis for all LNs; instead, a level-by-level analysis was performed. Additionally, the diagnosis of most benign lateral LNs was based on follow-up results. Despite these limitations, this study has important clinical implications. Our data confirmed that FNA-Tg is a reliable method for the recognition of metastatic disease in the lateral neck. Optimized lateral neck node dissection for patients with PTC might be performed based on an FNA-Tg cut-off of 16.8 ng/mL. It is important to note that a patient whose cytology was inadequate, with an elevated FNA-Tg (433.6 ng/mL) in the lateral compartment, underwent the removal of 21 LNs in the lateral neck and showed no metastatic lesions by postsurgery pathology. However, radioiodine-avid disease in the aspirated compartment was detected in the post-therapeutic whole-body scan. Accordingly, an FNA-Tg value of > 16.8 ng/mL in LLN might be a strong indicator for the existence of metastatic disease, even when it is not revealed by postsurgical analyses.

Conclusion

Diagnostic accuracies and cut-off values for FNA-Tg measurements differ between central and lateral cervical LNs. Regarding the diagnostic accuracy of lateral LNs, our standardized procedure was proved to be promising and should be considered to guide lateral neck dissection.

Acknowledgments

The authors thank Mr. Qi Fan and our colleagues for their helpful assistance.

Disclosures

Xi Jia, Yuanbo Wang, Yan Liu, Xiang Wang, Xiaobao Yao, Runyi Tao, Hui Liu, Aimin Yang, and Rui Gao have no disclosures to declare.
Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Unsere Produktempfehlungen

Die Chirurgie

Print-Titel

Das Abo mit mehr Tiefe

Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.

Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Anhänge

Supplementary Information

Below is the link to the electronic supplementary material.
Literatur
1.
Zurück zum Zitat Siegel RL, Miller KD, Jemal AJC. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.PubMedCrossRef Siegel RL, Miller KD, Jemal AJC. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.PubMedCrossRef
2.
Zurück zum Zitat Appetecchia M, Lauretta R, Barnabei A, et al. Epidemiology of simultaneous medullary and papillary thyroid carcinomas (MTC/PTC): an Italian Multicenter Study. Cancers (Basel). 2019;11(10):1516.CrossRef Appetecchia M, Lauretta R, Barnabei A, et al. Epidemiology of simultaneous medullary and papillary thyroid carcinomas (MTC/PTC): an Italian Multicenter Study. Cancers (Basel). 2019;11(10):1516.CrossRef
3.
Zurück zum Zitat Kim SK, Park I, Hur N, et al. Patterns, predictive factors, and prognostic impact of contralateral lateral lymph node metastasis in N1b papillary thyroid carcinoma. Ann Surg Oncol. 2017;24(7):1943–50.PubMedCrossRef Kim SK, Park I, Hur N, et al. Patterns, predictive factors, and prognostic impact of contralateral lateral lymph node metastasis in N1b papillary thyroid carcinoma. Ann Surg Oncol. 2017;24(7):1943–50.PubMedCrossRef
4.
Zurück zum Zitat Heng Y, Yang Z, Zhou L, et al. Risk stratification for lateral involvement in papillary thyroid carcinoma patients with central lymph node metastasis. Endocrine. 2020;68(2):320–8.PubMedCrossRef Heng Y, Yang Z, Zhou L, et al. Risk stratification for lateral involvement in papillary thyroid carcinoma patients with central lymph node metastasis. Endocrine. 2020;68(2):320–8.PubMedCrossRef
5.
Zurück zum Zitat Park YM, Wang SG, Lee JC, et al. Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: a prognostic factor of locoregional recurrence. Head Neck. 2016;38(Suppl 1):E1172–6.PubMedCrossRef Park YM, Wang SG, Lee JC, et al. Metastatic lymph node status in the central compartment of papillary thyroid carcinoma: a prognostic factor of locoregional recurrence. Head Neck. 2016;38(Suppl 1):E1172–6.PubMedCrossRef
6.
Zurück zum Zitat Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.PubMedPubMedCentralCrossRef Haugen BR, Alexander EK, Bible KC, et al. 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid. 2016;26(1):1–133.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Al-Hilli Z, Strajina V, McKenzie TJ, et al. Thyroglobulin measurement in fine-needle aspiration improves the diagnosis of cervical lymph node metastases in papillary thyroid carcinoma. Ann Surg Oncol. 2017;24(3):739–44.PubMedCrossRef Al-Hilli Z, Strajina V, McKenzie TJ, et al. Thyroglobulin measurement in fine-needle aspiration improves the diagnosis of cervical lymph node metastases in papillary thyroid carcinoma. Ann Surg Oncol. 2017;24(3):739–44.PubMedCrossRef
8.
Zurück zum Zitat Hoda RS. Nondiagnostic/unsatisfactory thyroid fine needle aspiration on liquid-based preparations. Atlas of thyroid cytopathology on liquid-based preparations. New York: Springer; 2020. p. 27–34.CrossRef Hoda RS. Nondiagnostic/unsatisfactory thyroid fine needle aspiration on liquid-based preparations. Atlas of thyroid cytopathology on liquid-based preparations. New York: Springer; 2020. p. 27–34.CrossRef
9.
Zurück zum Zitat Zhu Y, Song Y, Xu G, et al. Causes of misdiagnoses by thyroid fine-needle aspiration cytology (FNAC): our experience and a systematic review. Diagn Pathol. 2020;15(1):1–8.PubMedPubMedCentralCrossRef Zhu Y, Song Y, Xu G, et al. Causes of misdiagnoses by thyroid fine-needle aspiration cytology (FNAC): our experience and a systematic review. Diagn Pathol. 2020;15(1):1–8.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Koo DH, Song K, Kwon H, et al. Does tumor size influence the diagnostic accuracy of ultrasound-guided fine-needle aspiration cytology for thyroid nodules? Int J Endocrinol. 2016;2016:3803647.PubMedPubMedCentralCrossRef Koo DH, Song K, Kwon H, et al. Does tumor size influence the diagnostic accuracy of ultrasound-guided fine-needle aspiration cytology for thyroid nodules? Int J Endocrinol. 2016;2016:3803647.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat dos Santos Torres MR, Nobrega Neto SH, Rosas RJ, et al. Thyroglobulin in the washout fluid of lymph-node biopsy: what is its role in the follow-up of differentiated thyroid carcinoma? Thyroid. 2014;24(1):7–18.CrossRef dos Santos Torres MR, Nobrega Neto SH, Rosas RJ, et al. Thyroglobulin in the washout fluid of lymph-node biopsy: what is its role in the follow-up of differentiated thyroid carcinoma? Thyroid. 2014;24(1):7–18.CrossRef
12.
Zurück zum Zitat Li Q, Zhao B, Lu J. Diagnostic value of fine-needle aspiration and thyroglobulin measurement in fine-needle aspiration for node metastasis in thyroid carcinoma before thyroidectomy. Chin J Ultrason Med. 2016;32(5):400–3. Li Q, Zhao B, Lu J. Diagnostic value of fine-needle aspiration and thyroglobulin measurement in fine-needle aspiration for node metastasis in thyroid carcinoma before thyroidectomy. Chin J Ultrason Med. 2016;32(5):400–3.
13.
Zurück zum Zitat Kim MJ, Kim E-K, Kim BM, et al. Thyroglobulin measurement in fine-needle aspirate washouts: the criteria for neck node dissection for patients with thyroid cancer. Clin Endocrinol. 2009;70(1):145–51.CrossRef Kim MJ, Kim E-K, Kim BM, et al. Thyroglobulin measurement in fine-needle aspirate washouts: the criteria for neck node dissection for patients with thyroid cancer. Clin Endocrinol. 2009;70(1):145–51.CrossRef
14.
Zurück zum Zitat Chung J, Kim EK, Lim H, et al. Optimal indication of thyroglobulin measurement in fine-needle aspiration for detecting lateral metastatic lymph nodes in patients with papillary thyroid carcinoma. Head Neck. 2014;36(6):795–801.PubMedCrossRef Chung J, Kim EK, Lim H, et al. Optimal indication of thyroglobulin measurement in fine-needle aspiration for detecting lateral metastatic lymph nodes in patients with papillary thyroid carcinoma. Head Neck. 2014;36(6):795–801.PubMedCrossRef
15.
Zurück zum Zitat Lee JH, Lee HC, Yi HW, et al. Influence of thyroid gland status on the thyroglobulin cutoff level in washout fluid from cervical lymph nodes of patients with recurrent/metastatic papillary thyroid cancer. Head Neck. 2016;38:E1705–12.PubMedCrossRef Lee JH, Lee HC, Yi HW, et al. Influence of thyroid gland status on the thyroglobulin cutoff level in washout fluid from cervical lymph nodes of patients with recurrent/metastatic papillary thyroid cancer. Head Neck. 2016;38:E1705–12.PubMedCrossRef
16.
Zurück zum Zitat Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S plus to analyze and compare ROC curves. BMC Bioinform. 2011;12:77.CrossRef Robin X, Turck N, Hainard A, et al. pROC: an open-source package for R and S plus to analyze and compare ROC curves. BMC Bioinform. 2011;12:77.CrossRef
17.
Zurück zum Zitat Kaforou M, Herberg JA, Wright VJ, et al. Diagnosis of bacterial infection using a 2-transcript host RNA signature in febrile infants 60 days or younger. JAMA. 2017;317(15):1577–8.PubMedCrossRef Kaforou M, Herberg JA, Wright VJ, et al. Diagnosis of bacterial infection using a 2-transcript host RNA signature in febrile infants 60 days or younger. JAMA. 2017;317(15):1577–8.PubMedCrossRef
18.
Zurück zum Zitat Khadra H, Mohamed H, Al-Qurayshi Z, et al. Superior detection of metastatic cystic lymphadenopathy in patients with papillary thyroid cancer by utilization of thyroglobulin washout. Head Neck. 2019;41(1):225–9.PubMed Khadra H, Mohamed H, Al-Qurayshi Z, et al. Superior detection of metastatic cystic lymphadenopathy in patients with papillary thyroid cancer by utilization of thyroglobulin washout. Head Neck. 2019;41(1):225–9.PubMed
19.
Zurück zum Zitat Moon JH, Kim YI, Lim JA, et al. Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results. J Clin Endocrinol Metab. 2013;98(3):1061–8.PubMedCrossRef Moon JH, Kim YI, Lim JA, et al. Thyroglobulin in washout fluid from lymph node fine-needle aspiration biopsy in papillary thyroid cancer: large-scale validation of the cutoff value to determine malignancy and evaluation of discrepant results. J Clin Endocrinol Metab. 2013;98(3):1061–8.PubMedCrossRef
20.
Zurück zum Zitat Pak K, Suh S, Hong H, et al. Diagnostic values of thyroglobulin measurement in fine-needle aspiration of lymph nodes in patients with thyroid cancer. Endocrine. 2015;49(1):70–7.PubMedCrossRef Pak K, Suh S, Hong H, et al. Diagnostic values of thyroglobulin measurement in fine-needle aspiration of lymph nodes in patients with thyroid cancer. Endocrine. 2015;49(1):70–7.PubMedCrossRef
21.
Zurück zum Zitat Sohn Y-M, Kim MJ, Kim E-K, et al. Diagnostic performance of thyroglobulin value in indeterminate range in fine needle aspiration washout fluid from lymph nodes of thyroid cancer. Yonsei Med J. 2012;53(1):126–31.PubMedCrossRef Sohn Y-M, Kim MJ, Kim E-K, et al. Diagnostic performance of thyroglobulin value in indeterminate range in fine needle aspiration washout fluid from lymph nodes of thyroid cancer. Yonsei Med J. 2012;53(1):126–31.PubMedCrossRef
22.
Zurück zum Zitat Frasoldati A, Toschi E, Zini M, et al. Role of thyroglobulin measurement in fine-needle aspiration biopsies of cervical lymph nodes in patients with differentiated thyroid cancer. Thyroid. 1999;9(2):105–11.PubMedCrossRef Frasoldati A, Toschi E, Zini M, et al. Role of thyroglobulin measurement in fine-needle aspiration biopsies of cervical lymph nodes in patients with differentiated thyroid cancer. Thyroid. 1999;9(2):105–11.PubMedCrossRef
23.
Zurück zum Zitat Li J, Zhang K, Liu X, et al. Cervical lymph node thyroglobulin measurement in washout of fine-needle aspirates for diagnosis of papillary thyroid cancer metastases. Br J Biomed Sci. 2016;73(2):79–83.PubMedCrossRef Li J, Zhang K, Liu X, et al. Cervical lymph node thyroglobulin measurement in washout of fine-needle aspirates for diagnosis of papillary thyroid cancer metastases. Br J Biomed Sci. 2016;73(2):79–83.PubMedCrossRef
24.
Zurück zum Zitat Eun NL, Son EJ, Kim J-A, et al. Comparison of the diagnostic performances of ultrasonography, CT and fine needle aspiration cytology for the prediction of lymph node metastasis in patients with lymph node dissection of papillary thyroid carcinoma: a retrospective cohort study. Int J Surg. 2018;51:145–50.PubMedCrossRef Eun NL, Son EJ, Kim J-A, et al. Comparison of the diagnostic performances of ultrasonography, CT and fine needle aspiration cytology for the prediction of lymph node metastasis in patients with lymph node dissection of papillary thyroid carcinoma: a retrospective cohort study. Int J Surg. 2018;51:145–50.PubMedCrossRef
25.
Zurück zum Zitat Weetman APMA, Wheeler MH, Hall R. Extrathyroidal sites of autoantibody synthesis in Graves’ disease. Clin Exp Immunol. 1984;56(2):330–6.PubMedPubMedCentral Weetman APMA, Wheeler MH, Hall R. Extrathyroidal sites of autoantibody synthesis in Graves’ disease. Clin Exp Immunol. 1984;56(2):330–6.PubMedPubMedCentral
26.
Zurück zum Zitat Wang J, Jiang X, Xiao G, Zhou W, Hu Y. Excellent diagnostic performance of FNA-Tg in detecting lymph nodes metastases from papillary thyroid cancer. Future Oncol. 2020;16(33):2735–46.PubMedCrossRef Wang J, Jiang X, Xiao G, Zhou W, Hu Y. Excellent diagnostic performance of FNA-Tg in detecting lymph nodes metastases from papillary thyroid cancer. Future Oncol. 2020;16(33):2735–46.PubMedCrossRef
27.
Zurück zum Zitat Boi F, Baghino G, Atzeni F, et al. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies. J Clin Endocrinol Metab. 2006;91(4):1364–9.PubMedCrossRef Boi F, Baghino G, Atzeni F, et al. The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies. J Clin Endocrinol Metab. 2006;91(4):1364–9.PubMedCrossRef
28.
Zurück zum Zitat Uruno T, Miyauchi A, Shimizu K, et al. Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg. 2005;29(4):483–5.PubMedCrossRef Uruno T, Miyauchi A, Shimizu K, et al. Usefulness of thyroglobulin measurement in fine-needle aspiration biopsy specimens for diagnosing cervical lymph node metastasis in patients with papillary thyroid cancer. World J Surg. 2005;29(4):483–5.PubMedCrossRef
29.
Zurück zum Zitat Sigstad E, Heilo A, Paus E, et al. The usefulness of detecting thyroglobulin in fine-needle aspirates from patients with neck lesions using a sensitive thyroglobulin assay. Diagn Cytopathol. 2007;35(12):761–7.PubMedCrossRef Sigstad E, Heilo A, Paus E, et al. The usefulness of detecting thyroglobulin in fine-needle aspirates from patients with neck lesions using a sensitive thyroglobulin assay. Diagn Cytopathol. 2007;35(12):761–7.PubMedCrossRef
30.
Zurück zum Zitat Achille G, Garrisi VM, Russo S, et al. Thyroglobulin determination in fine needle aspiration biopsy washout of suspicious lymph nodes in thyroid carcinoma follow up. Endocr Metab Immune. 2017;17(3):213–8. Achille G, Garrisi VM, Russo S, et al. Thyroglobulin determination in fine needle aspiration biopsy washout of suspicious lymph nodes in thyroid carcinoma follow up. Endocr Metab Immune. 2017;17(3):213–8.
31.
Zurück zum Zitat Holmes BJ, Sokoll LJ, Li QK. Measurement of fine-needle aspiration thyroglobulin levels increases the detection of metastatic papillary thyroid carcinoma in cystic neck lesions. Cancer Cytopathol. 2014;122(7):521–6.PubMedCrossRef Holmes BJ, Sokoll LJ, Li QK. Measurement of fine-needle aspiration thyroglobulin levels increases the detection of metastatic papillary thyroid carcinoma in cystic neck lesions. Cancer Cytopathol. 2014;122(7):521–6.PubMedCrossRef
32.
Zurück zum Zitat Lee YH, Seo HS, Suh S, et al. Cut-off value for needle washout thyroglobulin in athyrotropic patients. Laryngoscope. 2010;120(6):1120–4.PubMedCrossRef Lee YH, Seo HS, Suh S, et al. Cut-off value for needle washout thyroglobulin in athyrotropic patients. Laryngoscope. 2010;120(6):1120–4.PubMedCrossRef
33.
Zurück zum Zitat Grani G. Fumarola angela, thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis of diagnostic accuracy. J Clin Endocrinol Metab. 2014;99(6):1970–82.PubMedCrossRef Grani G. Fumarola angela, thyroglobulin in lymph node fine-needle aspiration washout: a systematic review and meta-analysis of diagnostic accuracy. J Clin Endocrinol Metab. 2014;99(6):1970–82.PubMedCrossRef
34.
Zurück zum Zitat Sohn Y-M, Kwak JY, Kim E-K, et al. Diagnostic approach for evaluation of lymph node metastasis from thyroid cancer using ultrasound and fine-needle aspiration biopsy. Am J Roentgenol. 2010;194(1):38–43.CrossRef Sohn Y-M, Kwak JY, Kim E-K, et al. Diagnostic approach for evaluation of lymph node metastasis from thyroid cancer using ultrasound and fine-needle aspiration biopsy. Am J Roentgenol. 2010;194(1):38–43.CrossRef
35.
Zurück zum Zitat Wang Y, Zhao H, Wang Y-XJ, et al. Improvement in the detection of cystic metastatic papillary thyroid carcinoma by measurement of thyroglobulin in aspirated fluid. Biomed Res Int. 2016;2016:8905916.PubMedPubMedCentral Wang Y, Zhao H, Wang Y-XJ, et al. Improvement in the detection of cystic metastatic papillary thyroid carcinoma by measurement of thyroglobulin in aspirated fluid. Biomed Res Int. 2016;2016:8905916.PubMedPubMedCentral
36.
Zurück zum Zitat Zhao H, Wang Y, Wang M-J, et al. Influence of presence/absence of thyroid gland on the cutoff value for thyroglobulin in lymph-node aspiration to detect metastatic papillary thyroid carcinoma. BMC Cancer. 2017;17(1):296.PubMedPubMedCentralCrossRef Zhao H, Wang Y, Wang M-J, et al. Influence of presence/absence of thyroid gland on the cutoff value for thyroglobulin in lymph-node aspiration to detect metastatic papillary thyroid carcinoma. BMC Cancer. 2017;17(1):296.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Baldini E, Sorrenti S, Di Gioia C, et al. Cervical lymph node metastases from thyroid cancer: does thyroglobulin and calcitonin measurement in fine needle aspirates improve the diagnostic value of cytology? BMC Clin Pathol. 2013;13:7–7.PubMedPubMedCentralCrossRef Baldini E, Sorrenti S, Di Gioia C, et al. Cervical lymph node metastases from thyroid cancer: does thyroglobulin and calcitonin measurement in fine needle aspirates improve the diagnostic value of cytology? BMC Clin Pathol. 2013;13:7–7.PubMedPubMedCentralCrossRef
38.
Zurück zum Zitat Pacini F, Fugazzola L, Lippi F, et al. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses—a clue to the diagnosis of metastatic differentiated thyroid-cancer. J Clin Endocrinol Metab. 1992;74(6):1401–4.PubMed Pacini F, Fugazzola L, Lippi F, et al. Detection of thyroglobulin in fine needle aspirates of nonthyroidal neck masses—a clue to the diagnosis of metastatic differentiated thyroid-cancer. J Clin Endocrinol Metab. 1992;74(6):1401–4.PubMed
39.
Zurück zum Zitat Jeon SJ, Kim E, Park JS, et al. Diagnostic benefit of thyroglobulin measurement in fine-needle aspiration for diagnosing metastatic cervical lymph nodes from papillary thyroid cancer: correlations with US features. Korean J Radiol. 2009;10(2):106–11.PubMedPubMedCentralCrossRef Jeon SJ, Kim E, Park JS, et al. Diagnostic benefit of thyroglobulin measurement in fine-needle aspiration for diagnosing metastatic cervical lymph nodes from papillary thyroid cancer: correlations with US features. Korean J Radiol. 2009;10(2):106–11.PubMedPubMedCentralCrossRef
40.
Zurück zum Zitat Lee MJ, Ross DS, Mueller PR, et al. Fine-needle biopsy of cervical lymph-nodes in patients with thyroid-cancer—a prospective comparison of cytopathologic and tissue marker analysis. Radiology. 1993;187(3):851–4.PubMedCrossRef Lee MJ, Ross DS, Mueller PR, et al. Fine-needle biopsy of cervical lymph-nodes in patients with thyroid-cancer—a prospective comparison of cytopathologic and tissue marker analysis. Radiology. 1993;187(3):851–4.PubMedCrossRef
41.
Zurück zum Zitat Piotrkowski-Viale F, Reyes A, Dios A, et al. Effects of sample storage and diluents in the reliability of thyroglobulin measurement in the washout of fine needle aspirates. Endocrine. 2017;56(3):504–8.PubMedCrossRef Piotrkowski-Viale F, Reyes A, Dios A, et al. Effects of sample storage and diluents in the reliability of thyroglobulin measurement in the washout of fine needle aspirates. Endocrine. 2017;56(3):504–8.PubMedCrossRef
42.
Zurück zum Zitat Majstorov V, Gjorcheva D, Tripunoski T, et al. Thyroglobulin measurement in aspirates of neck lymph nodes in patients with benign and malignant thyroid disorders. Physioacta. 2015;9(3):27–35. Majstorov V, Gjorcheva D, Tripunoski T, et al. Thyroglobulin measurement in aspirates of neck lymph nodes in patients with benign and malignant thyroid disorders. Physioacta. 2015;9(3):27–35.
43.
Zurück zum Zitat Borel A, Boizel R, Faure P, et al. Significance of low levels of thyroglobulin in fine needle aspirates from cervical lymph nodes of patients with a history of differentiated thyroid cancer. Eur J Endocrinol. 2008;158(5):691–8.PubMedCrossRef Borel A, Boizel R, Faure P, et al. Significance of low levels of thyroglobulin in fine needle aspirates from cervical lymph nodes of patients with a history of differentiated thyroid cancer. Eur J Endocrinol. 2008;158(5):691–8.PubMedCrossRef
Metadaten
Titel
Thyroglobulin Measurement Through Fine-Needle Aspiration for Optimizing Neck Node Dissection in Papillary Thyroid Cancer
verfasst von
Xi Jia, MD
Yuanbo Wang, MD
Yan Liu, MD
Xiang Wang, MD
Xiaobao Yao, MD
Runyi Tao, BA
Hui Liu, MA
Aimin Yang, MD, PhD
Rui Gao, MD, PhD
Publikationsdatum
12.08.2021
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 1/2022
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-021-10549-2

Weitere Artikel der Ausgabe 1/2022

Annals of Surgical Oncology 1/2022 Zur Ausgabe

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.